CLINICAL TRIALS PROFILE FOR ENTOCORT EC
✉ Email this page to a colleague
All Clinical Trials for ENTOCORT EC
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00135408 ↗ | A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide | Completed | Medarex | Phase 2 | 2005-12-01 | The purpose of the study is to determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) administered with or without Prophylactic Oral Budesonide. |
NCT00135408 ↗ | A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide | Completed | Bristol-Myers Squibb | Phase 2 | 2005-12-01 | The purpose of the study is to determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) administered with or without Prophylactic Oral Budesonide. |
NCT00343642 ↗ | Dietary Treatment of Crohn's Disease | Completed | National Center for Complementary and Integrative Health (NCCIH) | Phase 1/Phase 2 | 2006-09-01 | Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD. |
NCT00343642 ↗ | Dietary Treatment of Crohn's Disease | Completed | Rush University Medical Center | Phase 1/Phase 2 | 2006-09-01 | Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ENTOCORT EC
Condition Name
Clinical Trial Locations for ENTOCORT EC
Trials by Country
Clinical Trial Progress for ENTOCORT EC
Clinical Trial Phase
Clinical Trial Sponsors for ENTOCORT EC
Sponsor Name